Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Retrospective, Multicenter, Observational Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

NCT05008874 is registered in ClinicalTrials.gov with SwanBio Therapeutics, Inc. as lead sponsor.

NCT NCT05008874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05008874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Retrospective, Multicenter, Observational Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia
Lead sponsor
SwanBio Therapeutics, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 21, 2021
Completion date
May 16, 2025
Enrollment
65 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

amn, amn gene mutation, x-ald